Literature DB >> 9559397

National tuberculin survey of Kenya, 1986-1990.

M C Bosman1, O B Swai, D O Kwamanga, R Agwanda, G Idukitta, O Misljenovic.   

Abstract

SETTING: The first tuberculin survey conducted in Kenya by the World Health Organisation in 1958-1959 found an annual risk of tuberculosis infection (ARTI) of 2.5%.
OBJECTIVE: To estimate the ARTI and its trend in recent years and to compare the estimated incidence rates with the notification rates.
DESIGN: A tuberculin survey was held in 12 randomly selected districts in the period 1986-1990. Tuberculin testing with 2TU PPD RT 23 + Tween 80 was performed in 40,365 primary schoolchildren aged 6-13.
RESULTS: Of 14,984 non BCG-vaccinated children, 1,380 (9.2%) had indurations of > or = 10 mm. Double testing with PPD RT 23 and PPD-scrofulaceum in 980 non BCG-vaccinated children revealed a high level of infections due to mycobacteria other than tuberculosis (MOTT). Therefore, the prevalence of tuberculous infection was based on the sum of 50% of the indurations of 17 mm and all indurations of 18 mm or more multiplied by two. The prevalence of tuberculous infection in schoolchildren aged on average 8.4 years, 'weighted' for the population size according to the provisional results of the 1989 census, was calculated at 5.5%. The corresponding ARTI is 0.6%.
CONCLUSION: The ARTI has declined by an average 4.6% per year. The tuberculosis problem differs from one area to the next, with the highest prevalences of infection on the coast and in Eastern Kenya, and the lowest in Western Kenya. Although the average ratio of observed and estimated incidences indicate that 70% of incident cases are notified, considerable inter-district variations are observed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9559397

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  8 in total

1.  Tuberculin sensitivity among children vaccinated with BCG under universal immunization programme.

Authors:  V K Chadha; P S Jaganath; P Kumar
Journal:  Indian J Pediatr       Date:  2004-12       Impact factor: 1.967

2.  Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients.

Authors:  T Mark Doherty; Abebech Demissie; Joseph Olobo; Dawit Wolday; Sven Britton; Tewodros Eguale; Pernille Ravn; Peter Andersen
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

3.  Tuberculosis and the HIV epidemic: increasing annual risk of tuberculous infection in Kenya, 1986-1996.

Authors:  J A Odhiambo; M W Borgdorff; F M Kiambih; D K Kibuga; D O Kwamanga; L Ng'ang'a; R Agwanda; N A Kalisvaart; O Misljenovic; N J Nagelkerke; M Bosman
Journal:  Am J Public Health       Date:  1999-07       Impact factor: 9.308

4.  What has Karonga taught us? Tuberculosis studied over three decades.

Authors:  A C Crampin; J R Glynn; P E M Fine
Journal:  Int J Tuberc Lung Dis       Date:  2009-02       Impact factor: 2.373

5.  A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements.

Authors:  L Wang; M O Turner; R K Elwood; M Schulzer; J M FitzGerald
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

6.  Analysis of latent tuberculosis and mycobacterium avium infection data using mixture models.

Authors:  José I Villate; Berta Ibáñez; Valentín Cabriada; José I Pijoán; Jorge Taboada; Arantza Urkaregi
Journal:  BMC Public Health       Date:  2006-09-28       Impact factor: 3.295

7.  A tuberculin skin test survey among Ghanaian school children.

Authors:  Kennedy Kwasi Addo; Susan van den Hof; Gloria Ivy Mensah; Adukwei Hesse; Christian Bonsu; Kwadwo Ansah Koram; Felix Kwami Afutu; Frank Adae Bonsu
Journal:  BMC Public Health       Date:  2010-01-26       Impact factor: 3.295

8.  Annual risk of tuberculous infection using different methods in communities with a high prevalence of TB and HIV in Zambia and South Africa.

Authors:  Kwame Shanaube; Charalambos Sismanidis; Helen Ayles; Nulda Beyers; Ab Schaap; Katherine-Anne Lawrence; Annie Barker; Peter Godfrey-Faussett
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.